GNCA LOSS NOTICE: Rosen Law Firm Reminds Genocea Biosciences, Inc. Investors of Important Deadline in Class Action – GNCA NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Genocea Biosciences, Inc. (NASDAQ:GNCA) from May 5, 2017...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Genocea Biosciences, Inc. – GNCA NEW YORK, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Genocea...

MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Global Opportunities" CAMBRIDGE, MA--(Marketwire - November 4, 2009) - On November 9, the MIT Enterprise Forum of Cambridge will present a session on the development of new technologies for the research, development and...